The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISLB 2022 | Role of liquid biopsy in lung and head & neck cancer
Luis Raez, MD, FACP, FCCP, Memorial Cancer Institute and Florida International University, Hollywood, FL, discusses the role of liquid biopsy in molecular profiling for improving personalized treatment for patients with lung or head and neck cancers. Dr Raez also highlights the progressive roles of liquid biopsy, for example for monitoring and predicting recurrence after surgery. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research Support: BMS, Genentech/Roche, Pfizer, Nanthealth, MSD, Merck Serono, Lilly Oncology, Boheringer-Ingelheim, Syndax, Novartis, Heat Biologics, Astra-Zeneca, Exosomes DX, Liquid Genomics, Loxo Oncology
